These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33824936)

  • 41. Superspreading and the effect of individual variation on disease emergence.
    Lloyd-Smith JO; Schreiber SJ; Kopp PE; Getz WM
    Nature; 2005 Nov; 438(7066):355-9. PubMed ID: 16292310
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Superspreading SARS events, Beijing, 2003.
    Shen Z; Ning F; Zhou W; He X; Lin C; Chin DP; Zhu Z; Schuchat A
    Emerg Infect Dis; 2004 Feb; 10(2):256-60. PubMed ID: 15030693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refining Reproduction Number Estimates to Account for Unobserved Generations of Infection in Emerging Epidemics.
    Brizzi A; O'Driscoll M; Dorigatti I
    Clin Infect Dis; 2022 Aug; 75(1):e114-e121. PubMed ID: 35176766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chopping the tail: how preventing superspreading can help to maintain COVID-19 control.
    Kain MP; Childs ML; Becker AD; Mordecai EA
    medRxiv; 2020 Jul; ():. PubMed ID: 32637966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility.
    Zhao S; Chong MKC; Ryu S; Guo Z; He M; Chen B; Musa SS; Wang J; Wu Y; He D; Wang MH
    PLoS Comput Biol; 2022 Jun; 18(6):e1010281. PubMed ID: 35759509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: A systematic review.
    Wang J; Chen X; Guo Z; Zhao S; Huang Z; Zhuang Z; Wong EL; Zee BC; Chong MKC; Wang MH; Yeoh EK
    Comput Struct Biotechnol J; 2021; 19():5039-5046. PubMed ID: 34484618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High variability in transmission of SARS-CoV-2 within households and implications for control.
    Toth DJA; Beams AB; Keegan LT; Zhang Y; Greene T; Orleans B; Seegert N; Looney A; Alder SC; Samore MH
    PLoS One; 2021; 16(11):e0259097. PubMed ID: 34758042
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploration of Superspreading Events in 2015 MERS-CoV Outbreak in Korea by Branching Process Models.
    Choe S; Kim HS; Lee S
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32846960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. SARS-CoV-2 incidence monitoring and statistical estimation of the basic and time-varying reproduction number at the early onset of the pandemic in 45 sub-Saharan African countries.
    Oduro MS; Arhin-Donkor S; Asiedu L; Kadengye DT; Iddi S
    BMC Public Health; 2024 Feb; 24(1):612. PubMed ID: 38409118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects.
    Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N
    Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections.
    Illingworth CJ; Hamilton WL; Warne B; Routledge M; Popay A; Jackson C; Fieldman T; Meredith LW; Houldcroft CJ; Hosmillo M; Jahun AS; Caller LG; Caddy SL; Yakovleva A; Hall G; Khokhar FA; Feltwell T; Pinckert ML; Georgana I; Chaudhry Y; Curran MD; Parmar S; Sparkes D; Rivett L; Jones NK; Sridhar S; Forrest S; Dymond T; Grainger K; Workman C; Ferris M; Gkrania-Klotsas E; Brown NM; Weekes MP; Baker S; Peacock SJ; Goodfellow IG; Gouliouris T; de Angelis D; Török ME
    Elife; 2021 Aug; 10():. PubMed ID: 34425938
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak.
    Park SW; Bolker BM; Champredon D; Earn DJD; Li M; Weitz JS; Grenfell BT; Dushoff J
    J R Soc Interface; 2020 Jul; 17(168):20200144. PubMed ID: 32693748
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Latency on Estimates of the COVID-19 Replication Number.
    Sadun L
    Bull Math Biol; 2020 Aug; 82(9):114. PubMed ID: 32816135
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [SARS-CoV-2/COVID-19-epidemiology and prevention].
    Salzberger B; Buder F; Lampl B; Ehrenstein B; Hitzenbichler F; Holzmann T; Schmidt B; Hanses F
    Nephrologe; 2021; 16(1):3-9. PubMed ID: 33343742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 Superspreading Suggests Mitigation by Social Network Modulation.
    Nielsen BF; Simonsen L; Sneppen K
    Phys Rev Lett; 2021 Mar; 126(11):118301. PubMed ID: 33798363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved inference of time-varying reproduction numbers during infectious disease outbreaks.
    Thompson RN; Stockwin JE; van Gaalen RD; Polonsky JA; Kamvar ZN; Demarsh PA; Dahlqwist E; Li S; Miguel E; Jombart T; Lessler J; Cauchemez S; Cori A
    Epidemics; 2019 Dec; 29():100356. PubMed ID: 31624039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Estimating the effective reproduction number for heterogeneous models using incidence data.
    Jorge DCP; Oliveira JF; Miranda JGV; Andrade RFS; Pinho STR
    R Soc Open Sci; 2022 Sep; 9(9):220005. PubMed ID: 36133147
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.